ARCHIVES

GSK’s Votrient Approved For Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Bush Budget Reinforces Funding Trends, Reports Say.

July 13, 2001

Sept. 9 NCAB Meeting: Varmus: Expect Another CR For Funding The NIH Through Mid-December

September 19, 2014

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

New Publications

May 4, 1990

Nexon Heads Kennedy Committee Health Staff: Pepper Introduces Bill For May As “NCI Month”

January 16, 1987